Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
North Clin Istanb ; 7(5): 478-486, 2020.
Article in English | MEDLINE | ID: mdl-33163884

ABSTRACT

OBJECTIVE: This study aims to assess the change in the dimensions of the lumbar muscles in patients with chronic lower back pain using Magnetic Resonance Imaging (MRI) and to determine pre/post effects of surgery. METHODS: We enrolled 28 individuals (13F/15M; age: 45.39±11.56 years) whose L2-S1 muscle measurements were obtained using MRI, before and at follow-up 6-12 months after surgery. The control group comprising 37 individuals (18F/19M; age: 34.41±10.72 years) who had no lumbar pathology but for whom retrospective archive images were available. In the axial MRI analysis, the cross-sections of m.multifidus, mm.erector spinae and m.psoas major on both sides were measured with the 'closed polygon' technique. RESULTS: The L2-3 and L4-5 levels of the m.multifidus on the right side, the L2-3, L4-5 and L5-S1 levels of the m.multifidus and the L5-S1 levels of the mm. erector spinae on the left side cross-sectional areas were significantly lower than the control group (p<0.05). The right-side m.multifidus and the left-side mm.erector spinae sectional areas were significantly lower than the pre-surgery values at the L5-S1 levels (p<0.05). CONCLUSION: This study demonstrated that chronic lower back pain causes atrophy in the lumbar muscles and established the existence and continuity of atrophy after surgery.

2.
Clin Neurol Neurosurg ; 193: 105778, 2020 06.
Article in English | MEDLINE | ID: mdl-32200216

ABSTRACT

OBJECTIVES: To investigate the effect of deep brain stimulation of the subthalamic nucleus (STN-DBS) and to compare low-frequency versus high-frequency STN-DBS on hemodynamic parameters of the middle cerebral artery between patients with advanced Parkinson's disease and age-sex matched healthy controls. PATIENTS AND METHODS: Eighteen patients with advanced Parkinson's disease (PD) with bilateral STN-DBS and 18 control subjects underwent Transcranial Doppler Ultrasound (TCDU) were included in the study. The hemodynamic parameters including blood flow velocity (FV), pulsatility index (PI) and, resistance index (RI) of the right middle cerebral artery (MCA) were measured and compared during the phases using TCDU. The first DBS-off, the second low-frequency DBS of 60 Hz, and the third high-frequency DBS of 130 Hz were compared. RESULTS: PD patients had significantly higher MCA-PI values compared with controls (0.99 ± 0.27 vs. 0.82 ± 0.14) (p = 0.031). Also, the MCA-PI values were higher in the low-frequency DBS (0.94 ± 0.14) and high-frequency DBS (0.93 ± 0.16) than in the controls (0.82 ± 0.14) (p = 0.022 and p = 0.041, respectively). There were no significant differences of FV and RI values among the DBS-on, DBS-off and, controls. The RI values were higher in the PD patients than in the controls, although these were not statistically significant. Also, PI values of the MCA decrease in different frequencies (60 Hz or 130 Hz). CONCLUSION: The results of this study showed that MCA-PI values are higher in advanced PD compared with controls. These indices indicate that MCA resistances and impedances are increased in advanced PD. Low- or high-frequency DBS treatment have beneficial effect to reduce high PI in advanced PD patients.


Subject(s)
Cerebrovascular Circulation , Deep Brain Stimulation/methods , Hemodynamics , Parkinson Disease/diagnostic imaging , Parkinson Disease/therapy , Subthalamic Nucleus/diagnostic imaging , Adult , Aged , Blood Flow Velocity , Female , Humans , Male , Middle Aged , Middle Cerebral Artery/physiopathology , Parkinson Disease/physiopathology , Ultrasonography, Doppler, Transcranial , Vascular Resistance
3.
Neurol Sci ; 39(10): 1683-1689, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29938340

ABSTRACT

INTRODUCTION: Parkinson's disease (PD) is the second most frequent progressive neuro-degenerative disorder. In addition to motor symptoms, nonmotor symptoms and voice and speech disorders can also develop in 90% of PD patients. The aim of our study was to investigate the effects of DBS and different DBS frequencies on speech acoustics of vowels in PD patients. METHODS: The study included 16 patients who underwent STN-DBS surgery due to PD. The voice recordings for the vowels including [a], [e], [i], and [o] were performed at frequencies including 230, 130, 90, and 60 Hz and off-stimulation. The voice recordings were gathered and evaluated by the Praat software, and the effects on the first (F1), second (F2), and third formant (F3) frequencies were analyzed. RESULTS: A significant difference was found for the F1 value of the vowel [a] at 130 Hz compared to off-stimulation. However, no significant difference was found between the three formant frequencies with regard to the stimulation frequencies and off-stimulation. In addition, though not statistically significant, stimulation at 60 and 230 Hz led to several differences in the formant frequencies of other three vowels. CONCLUSION: Our results indicated that STN-DBS stimulation at 130 Hz had a significant positive effect on articulation of [a] compared to off-stimulation. Although there is not any statistical significant stimulation at 60 and 230 Hz may also have an effect on the articulation of [e], [i], and [o] but this effect needs to be investigated in future studies with higher numbers of participants.


Subject(s)
Articulation Disorders/therapy , Deep Brain Stimulation , Parkinson Disease/therapy , Phonetics , Speech Acoustics , Subthalamic Nucleus , Adult , Aged , Articulation Disorders/etiology , Articulation Disorders/physiopathology , Deep Brain Stimulation/methods , Female , Follow-Up Studies , Humans , Male , Middle Aged , Parkinson Disease/physiopathology , Subthalamic Nucleus/physiopathology , Treatment Outcome
4.
Spine (Phila Pa 1976) ; 43(14): 977-983, 2018 07 15.
Article in English | MEDLINE | ID: mdl-29280933

ABSTRACT

STUDY DESIGN: A multicenter retrospective study of patients who underwent unilateral and bilateral balloon kyphoplasty. OBJECTIVE: The aim of this study was to compare the radiographic and clinical results of unilateral and bilateral balloon kyphoplasty to treat osteoporotic vertebral compression fractures. SUMMARY OF BACKGROUND DATA: Percutaneous kyphoplasty has long been used as a successful method in the treatment of osteoporotic vertebral compression fractures. Although the bilateral approach is considered to be the mainstay application of percutaneous kyphoplasty, the unilateral approach has also been shown to be sufficient and even more effective in some cases. METHODS: A total of 87 patients who underwent percutaneous kyphoplasty due to osteoporotic vertebral compression fractures between 2009 and 2016 were retrospectively evaluated and divided into two groups as patients who underwent unilateral or bilateral percutaneous kyphoplasty. Unilateral percutaneous kyphoplasty was performed in 36 and bilateral percutaneous kyphoplasty in 51 patients. The groups were compared in terms of clinical outcomes, radiological findings, and complications. Clinical outcomes were evaluated using Visual Analogue Scale and Oswestry Disability Index and the radiological findings were evaluated by comparing the preoperative and postoperative day 1 and year 1 values of anterior, middle, and posterior vertebral heights and kyphosis angle. RESULTS: Clinical improvement occurred in both groups but no significant difference was observed. In radiological workup, no significant difference was found between the groups in terms of improvements in vertebral heights and kyphosis angle. Operative time and the amount of cement used for the surgery were significantly lower in the patients that underwent unilateral kyphoplasty. CONCLUSION: Unilateral percutaneous kyphoplasty is as effective as bilateral percutaneous kyphoplasty both radiologically and clinically. Operative time and the amount of cement used for the surgery are significantly lower in unilateral kyphoplasty, which may play a role in decreasing complication rates. LEVEL OF EVIDENCE: 3.


Subject(s)
Fractures, Compression/diagnostic imaging , Fractures, Compression/surgery , Kyphoplasty/methods , Spinal Fractures/diagnostic imaging , Spinal Fractures/surgery , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Kyphoplasty/trends , Male , Middle Aged , Pain Measurement/methods , Pain Measurement/trends , Retrospective Studies
5.
Medicine (Baltimore) ; 96(39): e8185, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28953678

ABSTRACT

Ventriculoperitoneal shunt systems that are used in the treatment of normal pressure hydrocephalus are often associated with drainage problems. Adjustable shunt systems can prevent or treat these problems, but they may be expensive. The aim of our study is to compare the complications and total cost of several shunt systems.Patients with normal pressure hydrocephalus who underwent ventriculoperitoneal shunting between 2011 and 2016 were included in the study. The study involves patient consent and the informed consent was given. Complications and the average cost per person were compared between patients with adjustable and nonadjustable shunts. Shunt prices, surgical complications, and revision costs were taken into account to calculate the average cost.Of the 110 patients who were evaluated, 80 had a nonadjustable shunt and 30 had an adjustable shunt. In the group with adjustable shunts, the rates of subdural effusion and hematoma were 19.73% and 3.29%, respectively. In the group with nonadjustable shunts, these rates were 22.75% and 13.75%, respectively. One patient in the adjustable group underwent surgery for subdural hematoma, while 8 patients in the nonadjustable group underwent the same surgery. Ten patients required surgical intervention for subdural effusion and existing shunt systems in these patients were replaced by an adjustable shunt system. When these additional costs were factored into the analysis, the difference in cost between the shunt systems was reduced from 600 United States dollars (USD) to 111 USD.When the complications and additional costs that arise during surgical treatment of normal pressure hydrocephalus were considered, the price difference between adjustable and nonadjustable shunt systems was estimated to be much lower.


Subject(s)
Hydrocephalus, Normal Pressure/surgery , Postoperative Complications , Prosthesis Fitting/methods , Ventriculoperitoneal Shunt , Adult , Aged , Costs and Cost Analysis , Equipment Failure Analysis , Female , Humans , Hydrocephalus, Normal Pressure/epidemiology , Male , Middle Aged , Outcome and Process Assessment, Health Care , Postoperative Complications/diagnosis , Postoperative Complications/economics , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Reoperation/economics , Reoperation/methods , Reoperation/statistics & numerical data , Turkey/epidemiology , Ventriculoperitoneal Shunt/adverse effects , Ventriculoperitoneal Shunt/classification , Ventriculoperitoneal Shunt/economics , Ventriculoperitoneal Shunt/methods
6.
Childs Nerv Syst ; 33(9): 1599-1602, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28578512

ABSTRACT

INTRODUCTION: Colloid cysts are the most common pathologic lesions of the third ventricle. Although they are histologically benign, they may grow and can cause the hydrocephalus. A 5-year-old male patient underwent to surgery with the diagnosis of colloid cyst. In operation, after the anterior transcallosal approach, the cyst was punctured by syringe and obviously pus aspirated. CONCLUSION: Colloid cysts mostly remain silent and detected incidentally. Although it is rarely defined, rhinorrhea, hypopituitarism, diabetes insipidus, spasmodic torticollis, drop attack, aseptic meningitis, and coexistence with neurocysticercosis have been reported, but this is the first reported case of an infected colloid cyst.


Subject(s)
Colloid Cysts/pathology , Child, Preschool , Colloid Cysts/surgery , Humans , Male
7.
Neurocir. - Soc. Luso-Esp. Neurocir ; 25(3): 128-131, mayo-jun. 2014. ilus
Article in English | IBECS | ID: ibc-128140

ABSTRACT

A 19-year-old female with sickle cell anemia (SCD) was referred to our hospital after two days of hospitalization at another hospital for a headache crisis. This headache crisis was due to a raised intracranial pressure; these symptoms were noted and included in her comprehensive list of symptoms. There was an acute drop in the hemoglobin and hematocrit levels. The cranial CT scan demonstrated a left fron to-parietal acute epidural hematoma (AEH)and a calvarial bone expansion, which was suggestive of medullary hematopoiesis. The patient underwent emergent craniotomy and evacuation of the hematoma. There were noabnormal findings intra-operatively apart from the AEH, except skull thickening and active petechial bleeding from the dural arteries. Repeated CT scan showed a complete evacuation of the hematoma. The possible underlying path physiological mechanisms were discussed. In addition to the factors mentioned in the relevant literature, any active petechial bleeding from the dural arteries on the separated surface of the dura from the skull could have contributed to the expanding of the AEH in our patient. Neurosurgeons and other health care providers should be aware of spontaneous AEH in patients with SCD


Una mujer de 19 años con anemia de células falciformes (anemia drepanocítica) fue remitida a nuestro hospital tras 2 días de hospitalización en otro centro, debido a una crisis de migraña. Dicha crisis de migraña fue debida a un incremento de la presión intracraneal; se anotaron dichos síntomas y se incluyeron en su amplia lista de síntomas. Se produjo un pico agudo en los niveles de hemoglobina y de hematocrito. El escáner craneal mostró un hematoma epidural agudo fronto-parietal izquierdo y una expansión del hueso de la bóveda craneal, que indicaba una hematopoyesis medular. Se sometió a la paciente a una craneotomía de urgencia y a una evacuación del hematoma. Aparte de la anemia de células falciformes, los hallazgos intraoperatorios fueron: adelgazamiento craneal y petequia activa de las arterias durales. La repetición del escáner mostró la evacuación total del hematoma. Se analizaron los posibles mecanismos patofisiológicos subyacentes. Además de los factores mencionados en la literatura relevante, cualquier sangrado petequial activo de las arterias durales sobre la superficie separada de la duramadre, desde el cráneo, podría haber contribuido a la expansión del hematoma epidural agudo en nuestra paciente. Los neurocirujanos y demás facultativos sanitarios deberían tener conocimiento del hematoma epidural agudo espontáneo en pacientes con anemia de células falciformes


Subject(s)
Humans , Female , Young Adult , Anemia, Sickle Cell/complications , Hematoma, Epidural, Cranial/surgery , Hematopoiesis/physiology , Suction , Craniotomy , Risk Factors
8.
Neurocirugia (Astur) ; 25(3): 128-31, 2014.
Article in English | MEDLINE | ID: mdl-24447643

ABSTRACT

A 19-year-old female with sickle cell anemia (SCD) was referred to our hospital after two days of hospitalization at another hospital for a headache crisis. This headache crisis was due to a raised intracranial pressure; these symptoms were noted and included in her comprehensive list of symptoms. There was an acute drop in the hemoglobin and hematocrit levels. The cranial CT scan demonstrated a left fronto-parietal acute epidural hematoma (AEH) and a calvarial bone expansion, which was suggestive of medullary hematopoiesis. The patient underwent emergent craniotomy and evacuation of the hematoma. There were no abnormal findings intra-operatively apart from the AEH, except skull thickening and active petechial bleeding from the dural arteries. Repeated CT scan showed a complete evacuation of the hematoma. The possible underlying pathophysiological mechanisms were discussed. In addition to the factors mentioned in the relevant literature, any active petechial bleeding from the dural arteries on the separated surface of the dura from the skull could have contributed to the expanding of the AEH in our patient. Neurosurgeons and other health care providers should be aware of spontaneous AEH in patients with SCD.


Subject(s)
Anemia, Sickle Cell/complications , Hematoma, Epidural, Cranial/etiology , Acute Disease , Female , Humans , Young Adult
9.
Childs Nerv Syst ; 29(7): 1199-202, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23563809

ABSTRACT

BACKGROUND: Ventriculoperitoneal shunting is mostly used in the treatment of hydrocephalus, and many complications have been reported with this method. These complications include obstruction, mechanical shunt failure, infection, and abdominal complications. Abdominal complications include intestinal obstruction, volvulus, peritonitis, peritoneal cyst, cerebrospinal fluid ascites, as well as migration of the distal catheter via the intestinal tract, umbilicus, scrotum, and vagina. Various mechanisms have been suggested with regards to the catheter migration. CASE REPORT: We present a case of a 21-month-old female patient who had myelomeningocele at birth. She underwent repair of the myelomeningocele at the age of 10 days. After 4 months, cranial computed tomography revealed hydrocephalus, and ventriculoperitoneal shunt was placed. Because of shunt dysfunction, a new ventriculoperitoneal shunt system was installed at the age of 12 months. Eight months later, her mother noticed the protrusion of peritoneal catheter via abdominal wall and repaired myelomeningocele area. Revision of the lower end of the shunt was done, and myelomeningocele area was repaired again. CONCLUSION: We report a unique patient with the protrusion of the distal catheter through repaired myelomeningocele area and abdominal wall in the lumbar region.


Subject(s)
Abdominal Wall , Catheters, Indwelling , Foreign-Body Migration , Meningomyelocele/surgery , Postoperative Complications , Ventriculoperitoneal Shunt , Female , Humans , Imaging, Three-Dimensional , Infant , Reoperation , Tomography, X-Ray Computed
10.
Pediatr Neurosurg ; 49(3): 172-8, 2013.
Article in English | MEDLINE | ID: mdl-24801142

ABSTRACT

The aim of this study was to assess the effects of minocycline on cerebral ischemia-reperfusion (I/R) injury in rats. The study was carried out on 24 male Wistar albino rats, weighing 200-250 g, which were divided into three groups: (i) control (n = 8), (ii) I/R (n = 8) and (iii) I/R + minocycline (n = 8). Minocycline was administrated at a dose of 90 mg/kg p.o. to the I/R group 48, 24 and 1 h before ischemia. Following bilateral exposure of the common carotid arteries by anterior cervical dissection and separation of the vagus nerve, I/R injury was performed by occlusion. Following reperfusion, malondialdehyde (MDA), superoxide dismutase, glutathione peroxidase and catalase levels in the blood and brain tissue, and creatine kinase (CK), CK-BB, lactate dehydrogenase (LDH), neuron-specific enolase (NSE) and protein S100ß levels in the blood were measured and the histopathological changes were monitored. Regarding histopathological evaluation, symptoms of degeneration were significantly improved in the I/R + minocycline group compared to the I/R-only group. Statistical analysis of the biochemical parameters revealed significant differences in MDA (p < 0.001), nitric oxide (p < 0.05), CK (p < 0.05) and CK-MB (p < 0.05) levels between the I/R + minocycline group and the I/R group. According to the literature, the effect of minocycline is firstly assessed by LDH, CK-MB, NSE and S-100ß analysis in addition to antioxidant status and histopathological analysis.


Subject(s)
Brain Ischemia/prevention & control , Brain/drug effects , Minocycline/therapeutic use , Neuroprotective Agents/therapeutic use , Reperfusion Injury/prevention & control , Animals , Brain/metabolism , Brain Ischemia/metabolism , Male , Minocycline/pharmacology , Neuroprotective Agents/pharmacology , Rats , Rats, Wistar , Reperfusion Injury/metabolism , Time Factors
11.
Pediatr Neurosurg ; 47(4): 254-60, 2011.
Article in English | MEDLINE | ID: mdl-22310070

ABSTRACT

BACKGROUND: Spinal cord injury (SCI) is a leading cause of morbidity and mortality among youth and adults. Secondary injury mechanisms within the spinal cord (SC) are well known to cause deterioration after an acute impact. Free radical scavengers are among the most studied agents in animal models of SCI. Edaravone is a scavenger of hydroxyl radicals. METHODS: We aimed to measure and compare the effects of both methylprednisolone and edaravone on tissue and on serum concentrations of nitric oxide (NO), malondialdehyde (MDA) levels, superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-Px) activity, and tissue total antioxidant capacity (TAC) in rats with SCI. SCI was induced in four groups of Wistar albino rats by a weight-drop method. The neurological function of the rats was periodically tested. At the end of the experiment, blood samples were collected, and SC tissue samples were harvested for biochemical evaluation. RESULTS: The tissue level of NO was decreased in the edaravone-treated group compared with the no-treatment group (p < 0.05). The tissue levels of SOD and GSH-Px were higher in the edaravone-treated group than in the no-treatment group (p < 0.05). The serum levels of NO were lower in the edaravone-treated and methylprednisolone-treated groups than in the no-treatment group (p < 0.05). The serum levels of SOD in the edaravone-treated group did not differ from those of any other group. The serum levels of MDA in the edaravone-treated and no-treatment groups were higher than in the two other groups (p < 0.05). Tissue levels of MDA in the edaravone-treated group were lower than in the no-treatment group (p < 0.05). Tissue levels of TAC in the edaravone-treated group were higher than in the no-treatment and methylprednisolone-treated groups (p < 0.05). The neurological outcome scores of the animals in treatment groups did not depict any statistically significant improvement in motor functions. However, edaravone seemed to prevent further worsening of the immediate post-SCI neurological status. CONCLUSION: Our biochemical analyses indicate that edaravone is capable of blunting the increased oxidative stress that follows SCI. We show, for the first time, that edaravone enhances the TAC in SC tissue. This beneficial effect of edaravone on antioxidant status may act to minimize the secondary neurological damage that occurs during the acute phase after SCI.


Subject(s)
Antipyrine/analogs & derivatives , Free Radical Scavengers/pharmacology , Neuroprotective Agents/pharmacology , Spinal Cord Injuries/drug therapy , Spinal Cord/drug effects , Animals , Antipyrine/pharmacology , Disease Models, Animal , Edaravone , Male , Methylprednisolone/pharmacokinetics , Random Allocation , Rats , Rats, Wistar , Spinal Cord/physiopathology , Spinal Cord Injuries/physiopathology
12.
Neurosurgery ; 67(3 Suppl Operative): ons49-56; discussion ons56-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20679948

ABSTRACT

BACKGROUND: Flat-panel cone-beam computed tomography (FP-CBCT) has recently been introduced as a clinical feature in neuroangiography radiographic C-arm systems. OBJECTIVE: To introduce a method of positioning a surgical tool such as a needle or ablation probe within a target specified by intraoperative FP-CBCT scanning. METHODS: Two human cadaver and 2 porcine cadaver heads were injected with a mixture of silicone and contrast agent to simulate a contrast-enhanced tumor. Preoperative imaging was performed using a standard 1.5-T magnetic resonance imaging scanner. Intraoperative imaging was used to define the needle trajectory on a GE Innova 4100 flat panel-based neuroangiography C-arm system. RESULTS: Using a combination of FP-CBCT and fluoroscopy, a needle was successfully positioned within each of the simulated contrast-enhanced tumors, as verified by subsequent FP-CBCT scans. CONCLUSIONS: This proof-of-concept study demonstrates the potential utility of combining FP-CBCT scanning with fluoroscopy to position surgical tools when stereotactic devices and image-guided surgery systems are not available. However, further work is required to fully characterize the precision and accuracy of the method in a variety of realistic surgical sites.


Subject(s)
Cone-Beam Computed Tomography/instrumentation , Cone-Beam Computed Tomography/methods , Fluoroscopy/instrumentation , Fluoroscopy/methods , Surgery, Computer-Assisted/instrumentation , Surgery, Computer-Assisted/methods , Animals , Cadaver , Contrast Media , Humans , Magnetic Resonance Imaging/methods , Swine
13.
Neurol Neurochir Pol ; 44(3): 304-7, 2010.
Article in English | MEDLINE | ID: mdl-20625967

ABSTRACT

Hydatid cyst disease is a parasitic illness that is rarely located in the brain. We present a case of a 26-year-old female who complained of headache, nausea, and vomiting. The diagnosis was intracranial hydatid cyst disease and was confirmed with radiological and serological tests. Neurological examination revealed papilloedema and left-sided pyramidal signs. She was operated on using the Dowling-Orlando technique. The cyst was removed without rupture, and therapy was completed with albendazole for a period of four weeks. In this article, we discuss the application of the Dowling-Orlando technique, microsurgery, the Valsalva manoeuvre and the positioning of the patient such that gravity could facilitate surgical removal of a giant cerebral hydatid cyst.


Subject(s)
Brain Diseases/parasitology , Brain Diseases/surgery , Echinococcosis/diagnosis , Echinococcosis/surgery , Adult , Brain/parasitology , Brain/surgery , Female , Humans , Microsurgery/methods , Neurosurgical Procedures/methods , Treatment Outcome
14.
J Clin Neurosci ; 17(2): 182-6, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20006508

ABSTRACT

Patients with sickle cell disease (SCD) who have deformities and vertebral fractures due to osteoporosis may require surgery. Spinal surgeons must become familiar with the vertebral morphometry of patients with SCD and to that aim we have examined the morphometry of the thoracolumbar spine in these patients. A cohort of 100 patients with SCD was examined using plain thoraco lumbar anteroposterior/lateral radiographs and dual energy X-ray absorptiometry (DEXA). Vertebral morphometry (vertebral body diameters, pedicle, spinal canal and deformity) was assessed for different age groups. Results were compared to published studies of healthy subjects. The vertebral dimensions for the 16-20-year and the 21+-year-old groups were significantly smaller for females than males at most spinal levels, while measurements in the 6-10 years and 11-15 years age groups were similar across both sexes at most levels. No significant statistical difference was found between the diameters of the right and left pedicles. With the exception of the sagittal diameter, most of the dimensions of the vertebral bodies measured in SCD patients were less than those of healthy individuals; multiple deformities were also observed. Low bone density was noted in 32 patients. Our data highlight the differences in vertebral bone mineral density, anatomy and deformities in patients with SCD compared to healthy individuals. When considering surgical intervention for patients with SCD, it is important that pre-operative radiography and planning is undertaken, and that the surgeon is familiar with the geometry of the pedicles of the thoracolumbar vertebrae necessary for the safe insertion of pedicle screws. Osteoporosis must be considered when planning surgical interventions in these patients.


Subject(s)
Anemia, Sickle Cell/complications , Lumbar Vertebrae/diagnostic imaging , Osteoporosis/complications , Spinal Curvatures/diagnostic imaging , Spinal Fractures/diagnostic imaging , Thoracic Vertebrae/diagnostic imaging , Absorptiometry, Photon , Adolescent , Adult , Anthropometry/methods , Body Size/physiology , Bone Density/physiology , Bone Screws/standards , Child , Female , Humans , Infarction/etiology , Infarction/pathology , Infarction/physiopathology , Lumbar Vertebrae/pathology , Lumbar Vertebrae/surgery , Male , Osteoporosis/etiology , Preoperative Care/methods , Preoperative Care/standards , Radiology , Retrospective Studies , Sex Characteristics , Spinal Curvatures/etiology , Spinal Curvatures/surgery , Spinal Fractures/etiology , Spinal Fractures/surgery , Spinal Fusion/instrumentation , Spinal Fusion/methods , Thoracic Vertebrae/pathology , Thoracic Vertebrae/surgery , Young Adult
15.
J Clin Neurosci ; 17(3): 349-52, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19875292

ABSTRACT

Tadalafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Nitric oxide (NO) functions as a retrograde neurotransmitter in the spinal cord, and postsynaptic structures respond to NO by producing cGMP. The concentrations of cGMP in the spinal cord are controlled by the actions of PDE. The aim of the study was to evaluate and compare the effects of the use of both methylprednisolone and tadalafil on serum and tissue concentrations of NO, malondialdehyde (MDA) levels, superoxide dismutase (SOD) activity, and tissue glutathione peroxidase (GSH-Px) activity in rats with spinal cord injury (SCI). SCI was induced in Wistar albino rats by dropping a 10 g rod from a 5.0 cm height at T8-10. The 28 rats were randomly divided into four equal groups: tadalafil, methylprednisolone, non-treatment and sham groups. Rats were neurologically tested at 24 hours after trauma. At the end of the experiment, blood samples were collected and spinal cord tissue samples were harvested for biochemical evaluation. The tissue level of NO was increased in the tadalafil group compared with the non-treatment and methylprednisolone groups (p<0.05). The tissue levels of SOD and GSH-Px did not differ between the groups. Serum levels of NO were higher in the tadalafil group than in the non-treatment group (p<0.05). The increase in serum SOD levels was greater in the tadalafil group than the methylprednisolone group. Serum MDA levels in the tadalafil and methylprednisolone groups tended to be lower than in the non-treatment group (p>0.05). Tissue MDA levels in the tadalafil and methylprednisolone groups tended to be lower than in the non-treatment group and sham groups (p>0.05). Although there was no difference in neurological outcome scores between the tadalafil, methylprednisolone and non-treatment groups (p>0.05), the animals in the tadalafil and methylprednisolone groups tended to have better scores than the non-treatment group. Thus, tadalafil appears to be beneficial in reducing the effects of injury to the spinal cord by increasing tissue levels of NO and serum activity of SOD.


Subject(s)
Carbolines/pharmacology , Phosphodiesterase Inhibitors/pharmacology , Spinal Cord Injuries/prevention & control , Animals , Anti-Inflammatory Agents/pharmacology , Disease Models, Animal , Glutathione/metabolism , Male , Malondialdehyde/metabolism , Methylprednisolone/analogs & derivatives , Methylprednisolone/pharmacology , Methylprednisolone Acetate , Motor Activity/drug effects , Nitric Oxide/metabolism , Random Allocation , Rats , Rats, Wistar , Recovery of Function/drug effects , Spinal Cord Injuries/metabolism , Spinal Cord Injuries/physiopathology , Superoxide Dismutase/metabolism , Tadalafil , Treatment Outcome
16.
Pak J Pharm Sci ; 22(3): 313-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19553181

ABSTRACT

Effects of caffeic acid phenethyl ester (CAPE) on the serum S-100B levels were studied as an index for brain damage after permanent middle cerebral artery (MCA) occlusion in rabbits. Twenty rabbits were divided into four groups (n=5): control, sham, non-treatment and CAPE. The right MCA was occluded using a microsurgical procedure with bipolar coagulation and was then transected in non-treatment and CAPE groups. The rabbits in the sham group underwent a surgical procedure but the MCA was not occluded. No surgery was performed in the control group. CAPE was administered after MCA occlusion at the dose of 10 microg/kg, once a day intraperitoneally for 7 days in the CAPE group. Serum S-100B levels were determined on days 1, 2, 4 and 7. Serum S-100B level was significantly increased following permanent MCA occlusion. Posttreatment of CAPE significantly reduced the serum S-100B level. This study demonstrated that CAPE is capable of attenuating increased serum S-100B level induced by MCA occlusion in rabbits. CAPE may be useful as a neuroprotective agent.


Subject(s)
Brain Damage, Chronic/blood , Caffeic Acids/pharmacology , Infarction, Middle Cerebral Artery/blood , Nerve Growth Factors/blood , Neuroprotective Agents/pharmacology , Phenylethyl Alcohol/analogs & derivatives , S100 Proteins/blood , Animals , Biomarkers/metabolism , Brain Damage, Chronic/drug therapy , Caffeic Acids/therapeutic use , Infarction, Middle Cerebral Artery/drug therapy , Injections, Intraperitoneal , Male , Neuroprotective Agents/therapeutic use , Phenylethyl Alcohol/pharmacology , Phenylethyl Alcohol/therapeutic use , Rabbits , S100 Calcium Binding Protein beta Subunit
17.
Surg Radiol Anat ; 31(8): 645-7, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19367355

ABSTRACT

During the dissection of a posterior fossa in a cadaveric head, we found a solitary superior vermian artery (VA) originating from the posterior cerebral artery (PCA). On the right side, the VA arose from the precommunicating segment of the PCA. The VA distributed by giving off some branches to the interpeduncular fossa, cerebral peduncle, midbrain, cerebellar cortex, inferior colliculus, lingula, vermis and superior medullary velum. The right superior cerebellar artery (SCA) had a normal origin from the basilar artery (BA) and supplied the righ tentorial surface of the cerebellum by means of bifurcating into two major trunks. The left SCA had duplicated origin from the BA.


Subject(s)
Posterior Cerebral Artery/abnormalities , Cerebellum/blood supply , Humans
18.
Brain Res ; 1247: 11-20, 2009 Jan 09.
Article in English | MEDLINE | ID: mdl-18983835

ABSTRACT

Trimetazidine (TMZ) is an anti-ischemic agent which has been used for years as an effective anti-anginal agent in cardiac patients. The aim of the study was to investigate the effect of TMZ on the level of malondialdehyde (MDA), nitric oxide (NO), glutathione (GSH), catalase (CAT), histopathological changes and the number of myelinated axons in a crush injury model of sciatic nerve in rats. In this study, 50 Wistar albino rats were used and the right sciatic nerves of all animals were injured. They were randomly divided into two groups equal in number, called treatment and non-treatment groups. The animals were subdivided into four subgroups, non-injury/non-treatment (left sciatic nerves of non-treatment animals, NI-NT) and non-injury/treatment (left sciatic nerves of treatment animals, NI-T) and injury/non-treatment (right sciatic nerves of non-treatment animals, I-NT) and injury/treatment (right sciatic nerves of treatment animals, I-T). At the end of the experiment, the bilateral sciatic nerves and blood samples collected from these animals were analyzed using histological, stereological and biochemical methods. There was a progressive increase in the serum level of GSH and progressive decrease in serum MDA levels in the treatment group. Progressive decrease in serum NO levels was observed in the treatment groups and it was statistically significant on day 14 (p<0.05) compared to the non-treatment group. The activities of CAT were low in the treatment groups on days 21 (p<0.05) and 42 (p<0.05). In the NI-NT group, some unimportant degenerative changes such as irregularity in myelin sheets were observed. Many pathologic changes in the I-NT group and some minimal degeneration in the I-T group were observed. TMZ treatment resulted in increases in the myelinated axon numbers by a range of 223 to 604 in the I-NT group compared to the I-T. In conclusion, TMZ appears to be beneficial for induction of axonal regeneration and myelination in healthy nerves as well as injured nerves.


Subject(s)
Nerve Regeneration/drug effects , Oxidative Stress/drug effects , Sciatic Nerve/drug effects , Sciatic Nerve/injuries , Sciatic Neuropathy/drug therapy , Trimetazidine/pharmacology , Animals , Axons/drug effects , Axons/metabolism , Axons/pathology , Catalase/metabolism , Cell Count , Disease Models, Animal , Female , Glutathione/metabolism , In Vitro Techniques , Malondialdehyde/metabolism , Nerve Fibers, Myelinated/drug effects , Nerve Fibers, Myelinated/metabolism , Nerve Fibers, Myelinated/pathology , Nerve Regeneration/genetics , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Nitric Oxide/metabolism , Oxidative Stress/physiology , Rats , Rats, Wistar , Sciatic Nerve/physiopathology , Sciatic Neuropathy/metabolism , Sciatic Neuropathy/physiopathology , Treatment Outcome , Trimetazidine/therapeutic use , Vasodilator Agents/pharmacology , Vasodilator Agents/therapeutic use
19.
Turk Neurosurg ; 18(2): 172-6, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18597232

ABSTRACT

A 45-month-old child who had bitemporal arachnoid cysts and macrocephaly unrelated to glutaric aciduria type 1 (GA 1) was reported. The patient was admitted to the emergency unit after head trauma at 11 months of age. CT and MRI showed bitemporal arachnoid cysts (BACs). Acylcarnitine profile was normal in serum using tandem mass spectrometry. Urine and blood screening tests were within normal range for metabolic disorders. There were no unusual organic acids in urine and blood samples. No additional clinical findings of metabolic disorders such as GA 1 developed during follow-up. The majority of children affected with GA 1 have macrocephaly and BACs on CT or MRI. These signs should alert neurosurgeons to the possibility of GA 1. Neurosurgeons evaluating patients with head trauma or suspected non-accidental head injury should include GA 1 in the differential diagnosis of BACs associated with macrocephaly, and an evaluation should be performed.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Arachnoid Cysts/pathology , Craniocerebral Trauma/pathology , Glutaryl-CoA Dehydrogenase/blood , Head/abnormalities , Arachnoid Cysts/diagnostic imaging , Craniocerebral Trauma/diagnostic imaging , Diagnosis, Differential , Glutaryl-CoA Dehydrogenase/urine , Head/diagnostic imaging , Humans , Infant , Magnetic Resonance Imaging , Male , Tomography, X-Ray Computed
20.
Brain Res ; 1201: 135-42, 2008 Mar 27.
Article in English | MEDLINE | ID: mdl-18308295

ABSTRACT

The present study was conducted to investigate whether caffeic acid phenethyl ester (CAPE), an active component of propolis extract, has a protective effect on brain injury after focal permanent cerebral ischemia, and to determine the possible antioxidant mechanisms. Cerebral infarction in adult male New Zealand rabbits was induced by microsurgical procedures producing right focal permanent middle cerebral artery occlusion (pMCAO). CAPE was administered to the treatment group after pMCAO at a dose of 10 micromol kg(-1) once a day intraperitoneally for 7 days. Neurological deficits were evaluated, using a modified six-point scale. Spectrophotometric assay was used to determine the contents of malondialdehyde (MDA), glutathione (GSH), catalase (CAT), nitric oxide (NO) and xanthine oxidase (XO). In the ipsilateral hemisphere, the infarct volume of the brain was assessed in brain slices stained with heamatoxylen and eosin. The results showed that treatment with CAPE significantly reduced the percentage of infarction in the ipsilateral hemisphere compared with the ischemia group. CAPE treatment significantly attenuated the elevation of plasma MDA, CAT and XO content (p<0.05), whereas it significantly increased the levels of plasma GSH and NO (p<0.05). Therefore, subacute CAPE administration plays a protective role in focal pMCAO due to attenuation of lipid peroxidation and its antioxidant activity. All of these findings suggest that CAPE provides neuroprotection against cerebral ischemia injury through its antioxidant action.


Subject(s)
Antioxidants/pharmacology , Brain Infarction/drug therapy , Brain Ischemia/drug therapy , Caffeic Acids/pharmacology , Nerve Degeneration/drug therapy , Oxidative Stress/drug effects , Animals , Antioxidants/therapeutic use , Biomarkers/analysis , Biomarkers/metabolism , Brain Infarction/blood , Brain Infarction/pathology , Brain Ischemia/blood , Brain Ischemia/pathology , Brain Mapping , Caffeic Acids/therapeutic use , Catalase/analysis , Catalase/metabolism , Enzyme Inhibitors/pharmacology , Glutathione/analysis , Glutathione/metabolism , Image Processing, Computer-Assisted , Infarction, Middle Cerebral Artery/drug therapy , Infarction, Middle Cerebral Artery/metabolism , Infarction, Middle Cerebral Artery/physiopathology , Injections, Intraperitoneal , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Malondialdehyde/analysis , Malondialdehyde/metabolism , Nerve Degeneration/blood , Nerve Degeneration/pathology , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Nitric Oxide/analysis , Nitric Oxide/metabolism , Oxidative Stress/physiology , Phenylethyl Alcohol/analogs & derivatives , Rabbits , Spectrophotometry , Treatment Outcome , Xanthine Oxidase/analysis , Xanthine Oxidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...